Navigation Links
Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts

The new generation stents that are deigned for slow release of medication are found to be far more effective than conventional stents according to a recent study conducted on stents used for cardiac bypass // . It is also found to effectively prevent the overgrowth of scar tissue, thereby reducing incidence of restenosis (re-narrowing), heart attack and death.

Stents can either be inserted into a grafted vein or into a native coronary artery during a balloon angioplasty procedure. The plague-clogged area is opened up by the balloon followed by which a stent is placed to keep the vessel patent.

Veins removed from the legs (saphenous veins) are used to replace clogged arteries in the heart (coronary arteries). However, these grafts become old over a period of time. Infact nearly 50% of all vein grafts become diseased, necessitating a second intervention in the form of either a repeat open-heart surgery or balloon angioplasty with a reinsertion of a stent within 5 to 10 years of first cardiac surgery.

Some of the causes for restenosis include build up of plaque, cholesterol debris and blood clots that hinder with the patency of the graft. The incidence of re-stenosis is much greater in the saphenous vein grafts compared with percutaneous interventional procedure involving the native coronary arteries. The new stents were found to reduce the risk of re-stenosis by as much as 4 times compared to commercially available stents.

Out of the 223 patients who underwent angioplasty for treatment of diseased saphenous vein grafts (placed 8 years ago), 139 patients had drug-eluting stents placed. The rest of them had conventional stents placed.

The incidence of heart attacks, the necessity to reopen a vein graft was considerably lower among those fitted with a drug eluting stent with the reduction rates approximating to 4 and 10 compared to 20 and 37 in those fitted with a conventional stent.

Previous studies have already established that medicated stents are effective in the prevention of scar tissue formation and narrowing in the coronary arteries, the study is the first of it’s kind to explore the effectiveness in saphenous vein grafts.

The researchers intend to continue the study to find if similar results would be obtained on a long-term basis.


'"/>




Related medicine news :

1. Stronger Backing for Drug-Coated Stents
2. Drug-Coated Stents – Proven to be More Effectiv
3. The Efficacy Of Newer Stents Questioned
4. Analyzing The Side Effects Of Sirolimus Stents
5. Stents That Release Medication To Check Artery Narrowing
6. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Nitiol Stents A Better Alternative for the Conventional Stents
9. Does Life Saving Stents Actually Carry The Risk Of Blood Clots?
10. Bottleneck for Neck Stents - May Enhance Risk of Stroke, Says a Study
11. Using Heart Stents Tends to Form More Clots
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... January 16, 2017 , ... ... provide first-quality education and high-level training standards to an international multidisciplinary group of ... disorder problems. As a way to further its mission at the grassroots level, ...
(Date:1/15/2017)... NY (PRWEB) , ... January 15, 2017 , ... In ... accounts in the United States for the asthma & allergy friendly mark. This certification ... to independently test and identify consumer products to be more suitable for the 60+ ...
(Date:1/15/2017)... CA (PRWEB) , ... January 15, 2017 , ... ... their choice of best physicians in eight Bay Area counties for 2017. Almost ... the healthcare research company managing the award process. Results were announced the magazine’s ...
(Date:1/14/2017)... CA (PRWEB) , ... January 13, 2017 , ... ... on Body and Soul, incorporating a magnesium-rich Mediterranean diet may lower the risk ... Café and Lounge notes that the many health and wellness benefits linked to ...
(Date:1/13/2017)... ... 2017 , ... A January 10 article in the Daily Star ... publication, with an emphasis on some new techniques that the publication says are becoming ... more casually to his patients and colleagues as Dr. J, comments that the best ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... , January 16, 2017 According to a new ... Opportunity Analysis and Industry Forecast, 2014 - 2022," the global antioxidants market generated ... registering a CAGR of 6.42% during the forecast period. In the natural antioxidants ... volume in 2015. Continue Reading ... ...
(Date:1/16/2017)... , Jan. 16, 2017  Today, Analytics 4 Life ... devices, announced its expansion into JLABS @ ... life science incubators. As a resident in the space, ... medical device development and commercialization expertise. JLABS ... science innovation center that provides a flexible environment for ...
(Date:1/15/2017)... Le conseil d,administration de SurgaColl Technologies Ltd., le développeur ... de tissus humains, annonce la nomination de William (Bill) ... ... est un dirigeant expérimenté à l,international dans l,industrie des dispositifs ... de direction au sein de sociétés internationales spécialisées dans les ...
Breaking Medicine Technology: